The Oncosearch | Oncotarget

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

Sewanti Limaye, Prashant Kumar, Ramya Pragya, Janani Sambath, Darshana Patil, Ajay Srinivasan, Sachin Apurva, Navin Srivastava, Sanket Patil, Revati Patil, Vineet Datta, Dadasaheb Akolkar, Rajan Datar

Published Aug 4, 2022 · Vol. 13, No. 1 · pp. 982-982

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

Sujatha Muralidharan, Thibault Kervarrec, Glen J. Weiss, Mahtab Samimi

Published Jul 20, 2022 · Vol. 13, No. 1 · pp. 960-967

Keywords: Merkel cell carcinoma, glypican-3, Merkel cell polyomavirus, outcome

THIS IS A TEST PAPER - NOT FOR PRODUCTION Research Paper

Marina Baretti, Qingfeng Zhu, Wei Fu, Jeffrey Meyer, Hao Wang, Robert A. Anders, Nilofer S. Azad

Published Jul 13, 2022

Keywords: programmed death ligand 1, tumor-infiltrating lymphocytes, immune checkpoints, colorectal cancer, neoadjuvant chemoradiotherapy

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Francis R. LeBlanc, Zainul S. Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Violetta V. Leshchenko, Samir Parekh, Haiqing Fu, Ya Zhang, Melvenia M. Martin, Mark Kester, Todd Fox, Jiangang Liao, Thomas P. Loughran, Juanita Evans, Jeffrey J. Pu, Stephen E. Spurgeon, Mirit I. Aladjem, Elliot M. Epner

Published Jul 9, 2022 · Vol. 13, No. 1 · pp. 986-1002

Keywords: epigenetics, blastic mantle cell lymphoma, cladribine

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Andliena Tahiri, Katarina Puco, Faris Naji, Vessela N. Kristensen, Glenny Cecilie Alfsen, Lorant Farkas, Frode S. Nilsen, Stig Müller, Jan Oldenburg, Jürgen Geisler

Published Jul 8, 2022 · Vol. 13, No. 1 · pp. 970-981

Keywords: kidney cancer, kinase activity, tyrosine kinase inhibitors, renal cell carcinoma, tyrosine kinase

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer Research Paper

Marina Baretti, Qingfeng Zhu, Wei Fu, Jeffrey Meyer, Hao Wang, Robert A. Anders, Nilofer S. Azad

Published Jul 6, 2022 · Vol. 13, No. 1 · pp. 907-917

Keywords: programmed death ligand 1, tumor-infiltrating lymphocytes, immune checkpoints, colorectal cancer, neoadjuvant chemoradiotherapy

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Na Li, Lufei Wang, Guangyun Tan, Zhiheng Guo, Lei Liu, Ming Yang, Jin He

Published Jul 2, 2022 · Vol. 13, No. 1 · pp. 863-863

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Hai Liang, Jay-Hyun Jo, Zhiwei Zhang, Margaret A. MacGibeny, Jungmin Han, Diana M. Proctor, Monica E. Taylor, You Che, Paul Juneau, Andrea B. Apolo, John A. McCulloch, Diwakar Davar, Hassane M. Zarour, Amiran K. Dzutsev, Isaac Brownell, Giorgio Trinchieri, James L. Gulley, Heidi H. Kong

Published Jun 28, 2022 · Vol. 13, No. 1 · pp. 876-889

Keywords: gut microbiome, immunotherapy, 16S rRNA, machine learning, metagenomics

Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells Correction

Suthakar Ganapathy, Bo Peng, Ling Shen, Tianqi Yu, Jean Lafontant, Ping Li, Rui Xiong, Alexandros Makriyannis, Changyan Chen

Published Jun 28, 2022 · Vol. 14, No. 1 · pp. 148-148

Role of germline variants in the metastasis of breast carcinomas Research Paper

Ángela Santonja, Aurelio A. Moya-García, Nuria Ribelles, Begoña Jiménez-Rodríguez, Bella Pajares, Cristina E. Fernández-De Sousa, Elísabeth Pérez-Ruiz, María del Monte-Millán, Manuel Ruiz-Borrego, Juan de la Haba, Pedro Sánchez-Rovira, Atocha Romero, Anna González-Neira, Ana Lluch, Emilio Alba

Published Jun 27, 2022 · Vol. 13, No. 1 · pp. 843-862

Keywords: breast cancer, germline variants, epistasis, network analysis, seed and soil

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Raquel Torres-Guzmán, Maria Patricia Ganado, Cecilia Mur, Carlos Marugan, Carmen Baquero, Yanzhu Yang, Yi Zeng, Huimin Bian, Jian Du, Alfonso de Dios, Oscar Puig, María José Lallena

Published Jun 22, 2022 · Vol. 13, No. 1 · pp. 864-875

Keywords: abemaciclib, breast cancer, cell lines, CDK4/6, continuous dosing

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF Retraction

Peisong Wang, Xianying Meng, Yan Huang, Zhi Lv, Jia Liu, Guimin Wang, Wei Meng, Shuai Xue, Qiang Zhang, Pengju Zhang, Guang Chen

Published Jun 14, 2022 · Vol. 13, No. 1 · pp. 842-842

Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer Correction

Guozhong Jiang, Pengju Wang, Weiwei Wang, Wencai Li, Liping Dai, Kuisheng Chen

Published Jun 10, 2022 · Vol. 14, No. 1 · pp. 215-215

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction

Suparna Mazumder, Valerie Swank, Anton A. Komar, Justin M. Johnson, Vincent K. Tuohy

Published Jun 9, 2022 · Vol. 13, No. 1 · pp. 905-906

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Na Li, Lufei Wang, Guangyun Tan, Zhiheng Guo, Lei Liu, Ming Yang, Jin He

Published Jun 8, 2022

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Reyes Bernabé-Caro, Pilar Garrido, Rosario García-Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, Delvys Rodríguez-Abreu, Marta López-Brea, Alfredo Paredes, David Vicente, José Miguel Sánchez Torres, Margarita Majem, Pilar Diz, Rocío Gordo, Margarita Coca, Javier de Castro

Published Jun 7, 2022 · Vol. 13, No. 1 · pp. 812-827

Keywords: ALK-positive NSCLC, ALK inhibitor, crizotinib, alectinib, unselected patient

Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications Correction

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Yuki Uchida, Ryoji Hyakudomi, Tetsu Yamamoto, Kiyoe Takai, Yohei Sasaki, Koki Kawakami, Yoshitsugu Tajima

Published Jun 7, 2022 · Vol. 13, No. 1 · pp. 1092-1093

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, Daniel Antwi-Amoabeng, Ganiyu A. Rahman, Olatunji B. Alese

Published Jun 4, 2022 · Vol. 13, No. 1 · pp. 828-841

Keywords: pancreatic cancer, gastrointestinal malignancy, epidemiology, pancreatic adenocarcinoma

Targeting lipid metabolism in the treatment of ovarian cancer Review

Saliha Chaudhry, Stefani N. Thomas, Glenn E. Simmons Jr.

Published May 18, 2022 · Vol. 13, No. 1 · pp. 768-783

Keywords: ovarian cancer, lipid metabolism, biomarkers, microenvironment, fatty acid

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, Patrick Pauwels

Published May 13, 2022 · Vol. 13, No. 1 · pp. 800-809

Keywords: MGMT promoter methylation, anaplastic lymphoma kinase, neuroendocrine tumor, neuroendocrine carcinoma, small cell lung cancer

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

THIS IS A TEST PAPER - NOT FOR PRODUCTION Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer Research Paper

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells Correction

Role of germline variants in the metastasis of breast carcinomas Research Paper

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF Retraction

Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer Correction

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications Correction

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Targeting lipid metabolism in the treatment of ovarian cancer Review

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Addendum

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma Research Paper

THIS IS A TEST PAPER - NOT FOR PRODUCTION Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer Research Paper

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells Correction

Role of germline variants in the metastasis of breast carcinomas Research Paper

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation Research Paper

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF Retraction

Correction: Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer Correction

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II Correction

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 Retraction

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Correction: Influence of nutrition on stage-stratified survival in gastric cancer patients with postoperative complications Correction

Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival Review

Targeting lipid metabolism in the treatment of ovarian cancer Review

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper